Julia Schaft appointed new Managing Director at BioRN
Effective September 30, 2018, Fritz Richter retired from his roles as Managing Director of the BioRN Network e.V. and the BioRN Cluster Management GmbH, although he will stay actively connected to the organization.
We are pleased to announce that the boards of BioRN Network e.V. and BioRN Cluster Management GmbH have agreed to appoint Julia Schaft as the new managing director of both BioRN entities effective October 1, 2018. The appointment for the Network e.V. is still subject to the agreement of the members assembly in December.
Dr. Julia Schaft, Managing Director at BioRN
After completing her PhD in molecular and developmental biology at the University of Giessen and the European Molecular Biology Laboratory in Heidelberg (Germany) in 2002, Julia continued her scientific research on the differentiation of human embryonic stem cells at Genea Ltd in Sydney Australia, where she took over leadership responsibilities in scientific project management and the regulatory management of the company’s embryo research licences. Julia joined BioRN in 2015 as a project manager for international R&D and translational initiatives in the life sciences sector, and gradually took on BioRN strategic business development and partnering responsibilities.
“I am honoured to cover this position and look forward to continue the new strategic path laid together with Fritz and the BioRN Board over the past 2 years. Together with my team we will continue to develop the Rhine-Main-Neckar region into a world-leading life science cluster” said Julia when freshly appointed in her new role.
Best wishes for Julia in her new role and a lot of success and all the best for the future!
BioRN – Life Science Cluster Rhine-Neckar
BioRN is a life science research and industry cluster dedicated to the development of cell-specific, molecular and personalised innovative treatments. The BioRN Cluster stands for the development, networking, representation and promotion of the life science region into one of the leading life science clusters in Europe.
The cluster-members include renowned academic research institutions such as the Universities of Heidelberg, the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) and global health care companies such as AbbVie, Boehringer Ingelheim, Johnson & Johnson, Merck, Roche, und Sanofi-Aventis, and about 80 small and medium-sized biotech enterprises. Beyond the members registered in the cluster, BioRN gives access to a wider network via partnerships and collaborations.
In terms of the use of clusters for the internationalization of companies, BioRN has founded, together with Leuven (Belgium), Maastricht (Netherlands) and Copenhagen (Denmark), an alliance for the enforcement of biomedical innovation in Europe, called the Health Axis Europe.